Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase

• Published in: Prostaglandins & other lipid mediators 2016-03, Vol.123, p.16-27
• Main Authors: Khan, Ferdous, Syeda, Pinky Karim, Nartey, Michael Nii N., Rahman, Mohammad Shahidur, Islam, Mohammad Safiqul, Nishimura, Kohji, Jisaka, Mitsuo, Shono, Fumiaki, Yokota, Kazushige
• Format: Article
• Language: English
• Subjects: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; 6-Ketoprostaglandin F1 alpha - metabolism; Acetates - pharmacology; Adipocytes - cytology; Adipocytes - drug effects; Adipocytes - metabolism; Adipogenesis; Adipogenesis - drug effects; Adipogenesis - genetics; Animals; Arachidonic acid; Arachidonic Acid - pharmacology; Cell Differentiation - drug effects; Cells, Cultured; Cyclic AMP - metabolism; Cyclooxygenase 1 - genetics; Cyclooxygenase 1 - metabolism; Cyclooxygenase 2 - genetics; Cyclooxygenase 2 - metabolism; Cyclooxygenase Inhibitors - pharmacology; Differentiation phase; Dinoprost - metabolism; Dinoprostone - metabolism; Gene Expression Regulation - drug effects; Humans; Hydroxyprostaglandin Dehydrogenases - genetics; Hydroxyprostaglandin Dehydrogenases - metabolism; Membrane Proteins - antagonists & inhibitors; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mesenchymal Stem Cells - cytology; Mesenchymal Stem Cells - drug effects; Mesenchymal Stem Cells - metabolism; Mice; Preadipocyte; Prostaglandin; Prostaglandin-E Synthases - genetics; Prostaglandin-E Synthases - metabolism; Pyrazines - pharmacology; Receptors, Prostaglandin - antagonists & inhibitors; Receptors, Prostaglandin - genetics; Receptors, Prostaglandin - metabolism; Receptors, Prostaglandin E, EP4 Subtype - antagonists & inhibitors; Receptors, Prostaglandin E, EP4 Subtype - genetics; Receptors, Prostaglandin E, EP4 Subtype - metabolism; Signal Transduction; Triglycerides - metabolism
• ISSN: 1098-8823
• DOI: 10.1016/j.prostaglandins.2016.02.003

•Effect of pretreatment of preadipocytes with AA on adipogenesis was investigated.•AA stimulated adipogenesis program during differentiation phase without IBMX.•MRE-269, a selective agonist of IP, was the most potent instead of AA.•Exposure of preadipocytes to AA enhanced biosynthesis of pro-adipogenic PGI2.•AA suppressed endogenous synthesis of anti-adipogenic prostanoids in preadipoccytes. [Display omitted] Arachidonic acid (AA) and the related prostanoids exert complex effects on the adipocyte differentiation depending on the culture conditions and life stages. Here, we investigated the effect of the pretreatment of cultured 3T3-L1 preadipocytes with exogenous AA during the differentiation phase without 3-isobutyl-1-methylxanthine (IBMX), a cAMP-elevating agent, on the storage of fats after the maturation phase. This pretreatment with AA stimulated appreciably adipogenesis after the maturation phase as evident with the up-regulated gene expression of adipogenic markers. The stimulatory effect of the pretreatment with AA was attenuated by the co-incubation with each of cyclooxygenase (COX) inhibitors. Among exogenous prostanoids and related compounds, the pretreatment with MRE-269, a selective agonist of the IP receptor for prostaglandin (PG) I2, strikingly stimulated the storage of fats in adipocytes. The gene expression analysis of arachidonate COX pathway revealed that the transcript levels of inducible COX-2, membrane-bound PGE synthase-1, and PGF synthase declined more greatly in cultured preadipocytes treated with AA. By contrast, the expression levels of COX-1, cytosolic PGE synthase, and PGI synthase remained constitutive. The treatment of cultured preadipocytes with AA resulted in the decreased synthesis of PGE2 and PGF2α serving as anti-adipogenic PGs although the biosynthesis of pro-adipogenic PGI2 was up-regulated during the differentiation phase. Moreover, the gene expression levels of EP4 and FP, the respective prostanoid receptors for PGE2 and PGF2α, were gradually suppressed by the supplementation with AA, whereas that of IP for PGI2 remained relatively constant. Collectively, these results suggest the predominant role of endogenous PGI2 in the stimulatory effect of the pretreatment of cultured preadipoccytes with AA during the differentiation phase without IBMX on adipogenesis after the maturation phase.